Jasper Total Other Income Expense Net vs Other Operating Expenses Analysis

JSPR Stock  USD 23.87  1.95  8.90%   
Jasper Therapeutics financial indicator trend analysis is infinitely more than just investigating Jasper Therapeutics recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Jasper Therapeutics is a good investment. Please check the relationship between Jasper Therapeutics Total Other Income Expense Net and its Other Operating Expenses accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Jasper Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
To learn how to invest in Jasper Stock, please use our How to Invest in Jasper Therapeutics guide.

Total Other Income Expense Net vs Other Operating Expenses

Total Other Income Expense Net vs Other Operating Expenses Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Jasper Therapeutics Total Other Income Expense Net account and Other Operating Expenses. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Jasper Therapeutics' Total Other Income Expense Net and Other Operating Expenses is 0.53. Overlapping area represents the amount of variation of Total Other Income Expense Net that can explain the historical movement of Other Operating Expenses in the same time period over historical financial statements of Jasper Therapeutics, assuming nothing else is changed. The correlation between historical values of Jasper Therapeutics' Total Other Income Expense Net and Other Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Other Income Expense Net of Jasper Therapeutics are associated (or correlated) with its Other Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Operating Expenses has no effect on the direction of Total Other Income Expense Net i.e., Jasper Therapeutics' Total Other Income Expense Net and Other Operating Expenses go up and down completely randomly.

Correlation Coefficient

0.53
Relationship DirectionPositive 
Relationship StrengthWeak

Total Other Income Expense Net

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Jasper Therapeutics. It is also known as Jasper Therapeutics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.
Most indicators from Jasper Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Jasper Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Jasper Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
To learn how to invest in Jasper Stock, please use our How to Invest in Jasper Therapeutics guide.As of 05/01/2024, Selling General Administrative is likely to drop to about 16.2 K. In addition to that, Issuance Of Capital Stock is likely to drop to about 61.9 M
 2010 2023 2024 (projected)
Interest Income701K5.2M3.2M
Net Interest Income701K5.2M3.2M

Jasper Therapeutics fundamental ratios Correlations

0.750.970.870.32-0.87-0.88-0.97-0.871.01.00.940.940.451.00.95-0.89-0.530.140.950.880.880.50.681.00.5
0.750.850.74-0.26-0.89-0.93-0.81-0.970.750.730.810.85-0.070.730.74-0.86-0.840.070.740.590.90.450.870.74-0.15
0.970.850.820.15-0.94-0.93-0.94-0.940.970.960.970.980.320.960.95-0.92-0.580.170.950.820.90.540.750.970.31
0.870.740.82-0.01-0.78-0.77-0.92-0.860.830.870.790.770.10.870.86-0.87-0.73-0.310.860.830.940.090.750.870.34
0.32-0.260.15-0.010.09-0.1-0.240.120.340.330.190.160.980.330.140.030.330.610.140.28-0.060.55-0.330.320.85
-0.87-0.89-0.94-0.780.090.880.840.94-0.85-0.85-0.96-0.96-0.08-0.85-0.940.970.56-0.04-0.94-0.83-0.85-0.4-0.71-0.86-0.15
-0.88-0.93-0.93-0.77-0.10.880.920.96-0.9-0.87-0.91-0.94-0.29-0.87-0.810.890.75-0.29-0.82-0.73-0.91-0.65-0.76-0.88-0.17
-0.97-0.81-0.94-0.92-0.240.840.920.91-0.97-0.97-0.91-0.9-0.38-0.97-0.890.890.7-0.09-0.89-0.84-0.95-0.47-0.75-0.97-0.41
-0.87-0.97-0.94-0.860.120.940.960.91-0.87-0.86-0.91-0.92-0.06-0.86-0.870.940.8-0.02-0.87-0.75-0.96-0.42-0.85-0.87-0.07
1.00.750.970.830.34-0.85-0.9-0.97-0.871.00.930.940.481.00.92-0.86-0.540.210.920.830.880.560.691.00.48
1.00.730.960.870.33-0.85-0.87-0.97-0.861.00.930.920.461.00.94-0.87-0.530.140.940.860.880.490.691.00.5
0.940.810.970.790.19-0.96-0.91-0.91-0.910.930.930.990.350.930.96-0.96-0.50.190.960.910.840.550.60.930.4
0.940.850.980.770.16-0.96-0.94-0.9-0.920.940.920.990.330.920.94-0.95-0.530.240.950.860.850.60.660.930.32
0.45-0.070.320.10.98-0.08-0.29-0.38-0.060.480.460.350.330.460.27-0.120.190.690.270.380.090.69-0.190.460.82
1.00.730.960.870.33-0.85-0.87-0.97-0.861.01.00.930.920.460.94-0.87-0.530.140.940.860.880.490.691.00.5
0.950.740.950.860.14-0.94-0.81-0.89-0.870.920.940.960.940.270.94-0.95-0.45-0.031.00.940.840.340.620.940.45
-0.89-0.86-0.92-0.870.030.970.890.890.94-0.86-0.87-0.96-0.95-0.12-0.87-0.950.620.05-0.95-0.91-0.9-0.35-0.67-0.88-0.27
-0.53-0.84-0.58-0.730.330.560.750.70.8-0.54-0.53-0.5-0.530.19-0.53-0.450.620.16-0.45-0.36-0.85-0.19-0.85-0.530.24
0.140.070.17-0.310.61-0.04-0.29-0.09-0.020.210.140.190.240.690.14-0.030.050.16-0.01-0.04-0.10.91-0.150.140.19
0.950.740.950.860.14-0.94-0.82-0.89-0.870.920.940.960.950.270.941.0-0.95-0.45-0.010.930.840.350.620.940.44
0.880.590.820.830.28-0.83-0.73-0.84-0.750.830.860.910.860.380.860.94-0.91-0.36-0.040.930.740.30.380.870.63
0.880.90.90.94-0.06-0.85-0.91-0.95-0.960.880.880.840.850.090.880.84-0.9-0.85-0.10.840.740.310.880.880.15
0.50.450.540.090.55-0.4-0.65-0.47-0.420.560.490.550.60.690.490.34-0.35-0.190.910.350.30.310.190.490.25
0.680.870.750.75-0.33-0.71-0.76-0.75-0.850.690.690.60.66-0.190.690.62-0.67-0.85-0.150.620.380.880.190.68-0.24
1.00.740.970.870.32-0.86-0.88-0.97-0.871.01.00.930.930.461.00.94-0.88-0.530.140.940.870.880.490.680.51
0.5-0.150.310.340.85-0.15-0.17-0.41-0.070.480.50.40.320.820.50.45-0.270.240.190.440.630.150.25-0.240.51
Click cells to compare fundamentals

Jasper Therapeutics Account Relationship Matchups

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Jasper Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Jasper Therapeutics' short interest history, or implied volatility extrapolated from Jasper Therapeutics options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Jasper Therapeutics is a strong investment it is important to analyze Jasper Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Jasper Therapeutics' future performance. For an informed investment choice regarding Jasper Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Jasper Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
To learn how to invest in Jasper Stock, please use our How to Invest in Jasper Therapeutics guide.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Complementary Tools for Jasper Stock analysis

When running Jasper Therapeutics' price analysis, check to measure Jasper Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jasper Therapeutics is operating at the current time. Most of Jasper Therapeutics' value examination focuses on studying past and present price action to predict the probability of Jasper Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jasper Therapeutics' price. Additionally, you may evaluate how the addition of Jasper Therapeutics to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Is Jasper Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Jasper Therapeutics. If investors know Jasper will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Jasper Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(61.80)
Return On Assets
(0.60)
Return On Equity
(1.13)
The market value of Jasper Therapeutics is measured differently than its book value, which is the value of Jasper that is recorded on the company's balance sheet. Investors also form their own opinion of Jasper Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Jasper Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Jasper Therapeutics' market value can be influenced by many factors that don't directly affect Jasper Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Jasper Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Jasper Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Jasper Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.